The Veteran's bladder cancer is currently rated at 60 percent, but the Board finds that a higher rating may be warranted due to renal dysfunction. The case is remanded for an examination to assess the severity of any renal dysfunction residuals.
The deciding factor: The medical evidence does not adequately address the current severity of any renal dysfunction residuals due to service-connected bladder cancer.
- Claimed conditions
- Bladder Cancer
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- November 25, 2024
- Citation
- A24078038
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A24078038.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Board granted service connection for chronic obstructive pulmonary disease (COPD), bladder cancer, and lung cancer as secondary to the Veteran's in-service asbestos exposure.
- Denied
The Board denied service connection for obstructive sleep apnea, peripheral neuropathy of both upper and lower extremities, and bladder cancer as the evidence did not support a finding that these conditions were related to the Veteran's active military service or any service-connected disability.
- Dismissed
The issues of entitlement to restoration of basic eligibility for DEA benefits and an additional compensable rating for diabetic nephropathy were withdrawn by the Veteran, and are therefore dismissed.
- Granted
The Veteran's bladder cancer was granted as a presumptive disability due to herbicide exposure, and the effective date is set at August 10, 2022. The rating of 100% has been increased to cover the entire appeal period.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.